Van Andel Institute Study Rules Out Transcriptional Coactivators As Useful Herpes Antiviral Drug Targets
March 29, 2009 by admin
Researchers at Van Andel Research Institute (VARI) have determined that the herpes simplex virus type 1 (HSV-1) does not require transcriptional coactivators for viral gene expression early in the infection process. The finding is significant in determining that, in contradiction to earlier models, chemical inhibitors of these cellular proteins are not likely to serve as useful antiviral drugs.
Comments
Feel free to leave a comment...
and oh, if you want a pic to show with your comment, go get a gravatar!